IPO Issue Details
Issue Price / Price Band₹98 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,200 Shares per Lot
Total Issue Size45,88,800 shares (aggregating up to ₹44.97 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenNot Available
Subscription CloseNot Available
Basis of Allotment~6 days after close
Initiation of Refunds~7 days after close
Credit of Shares to Demat~7 days after close
Listing DateTue, 09 Dec 2025
UPI Mandate Deadline2025-12-04
Application & Investment Details
Retail — Min (2 Lots)₹2,35,200 — 2,400 shares
Retail — Max (13 Lots)₹1,528,800 (13 Lots)
HNI — Min (3 Lots)₹3,52,800 — 3,600 shares
QIB Quota47.38% of Issue
NII / HNI Quota14.28% of Issue
Retail Quota33.26% of Issue
Market Maker Quota5.07% of Issue
EPS (Pre-IPO)₹6.18
EPS (Post-IPO)₹6.41
P/E Ratio (Pre-IPO)15.85x
P/E Ratio (Post-IPO)15.3x
Net Offer to Public43,56,000 shares (aggregating up to ₹42.69 Cr)
Reserved for Market Maker2,32,800 shares (aggregating up to ₹2.28 Cr)
Pre-IPO Promoter Holding1,25,31,953 shares
Post-IPO Promoter Holding1,71,20,753 shares
About Neochem Bio Solutions Ltd.
Neochem Bio Solutions Ltd. is proposing an Initial Public Offering (IPO) on the NSE SME platform under the SME category.
The total issue size is 45,88,800 shares (aggregating up to ₹44.97 Cr).
The IPO subscription opens on the announced date and closes on the announced date. Listing is expected on 09 Dec 2025.
Investors can apply through ASBA or UPI via their broker app.
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,25,31,953 shares
Post-IPO Promoter Holding
1,71,20,753 shares
IPO Subscription Status
Listed on 09 Dec 2025
Final subscription figures recorded below
UPI Mandate Deadline: 2025-12-04
Important Dates
Subscription OpensTo be announced
Subscription ClosesTo be announced
Basis of Allotment~6 days after close
Listing DateTue, 09 Dec 2025
UPI Mandate Deadline2025-12-04
Lot Size & Investment Table
| Application | Lots | Shares | Amount |
|---|
| Retail (Min — 2 Lots) |
2 |
2,400 |
₹235,200 |
| Retail (Max — 13 Lots) |
13 |
15,600 |
₹1,528,800 |
| S-HNI (Min — 14 Lots) |
14 |
16,800 |
₹1,646,400 |
| S-HNI (Max — 66 Lots) |
66 |
79,200 |
₹7,761,600 |
| B-HNI (Min — 67 Lots) |
67 |
80,400 |
₹7,879,200 |
* Issue Price ₹98 × Lot Size 1,200 shares
Company Financials — Restated Consolidated
(Amount in ₹ Crore)
| Particulars |
30 Sep 2025 |
31 Mar 2025 |
31 Mar 2024 |
| Revenue from Operations |
47.18 |
86.15 |
62.01 |
| EBITDA |
8.59 |
13.11 |
5.99 |
| Profit After Tax (PAT) |
5.48 |
7.75 |
1.80 |
| Net Worth |
32.24 |
19.75 |
12.00 |
| Total Assets |
96.49 |
78.89 |
64.06 |
| Reserves & Surplus |
19.70 |
13.08 |
5.33 |
| Total Borrowings |
38.54 |
35.62 |
33.32 |
| EBITDA Margin (%) |
15.58% |
— | — |
| PAT Margin (%) |
9.00% |
— | — |
Key Ratios & Valuation
Issue Price₹98
Face Value₹10.00 Per Share
Price / Book Value (P/BV)5.80
Return on Equity (RoE)48.82%
Return on Capital Employed (RoCE)41.67%
Return on Net Worth (RoNW)48.82%
PAT Margin (%)9.00%
EBITDA Margin (%)15.58%
Debt / Equity Ratio1.80
Issue Structure & Shareholding
Total Shares Offered45,88,800 (100.00%)
Net Offer to Public43,56,000 shares (aggregating up to ₹42.69 Cr)
Reserved for Market Maker2,32,800 shares (aggregating up to ₹2.28 Cr)
Pre-Issue Promoter Holding1,25,31,953 shares
Post-Issue Promoter Holding1,71,20,753 shares
Script CodeNot Available
Objects of the Issue
Neochem Bio Solutions Ltd. proposes to utilize the net proceeds raised through this IPO for the following objects as stated in the Draft Red Herring Prospectus (DRHP) filed with SEBI:
Issue Composition & Shareholding
Issue TypeBookbuilding IPO
Sale TypeFresh Capital
Total Shares Offered45,88,800 (100.00%)
Net Offer to Public43,56,000 shares (aggregating up to ₹42.69 Cr)
Reserved for Market Maker2,32,800 shares (aggregating up to ₹2.28 Cr)
Pre-Issue Promoter Holding1,25,31,953 shares
Post-Issue Promoter Holding1,71,20,753 shares
